- Home
- MQ vs BLFS Comparison
MQ vs BLFS Comparison
Compare MQ & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MQ | BLFS |
|---|---|---|
| Founded | 2010 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.6B |
| IPO Year | 2021 | 2013 |
Fundamental Metrics
Financial Performance| Metric | MQ | BLFS |
|---|---|---|
| Price | $16.58 | $35.25 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 10 | 1 |
| Target Price | $5.36 | ★ $32.00 |
| AVG Volume (30 Days) | ★ 791.2K | 687.2K |
| Earning Date | 05-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 77.27 |
| EPS | N/A | ★ 0.94 |
| Revenue | ★ $624,884,000.00 | $96,214,000.00 |
| Revenue This Year | $16.89 | $19.73 |
| Revenue Next Year | $16.36 | $17.82 |
| P/E Ratio | ★ N/A | $37.58 |
| Revenue Growth | ★ 23.25 | 16.97 |
| 52 Week Low | $3.70 | $17.86 |
| 52 Week High | $18.69 | $38.10 |
Technical Indicators
Market Signals| Indicator | MQ | BLFS |
|---|---|---|
| Relative Strength Index (RSI) | 59.77 | 53.76 |
| Support Level | $16.52 | $23.93 |
| Resistance Level | $17.79 | $38.10 |
| Average True Range (ATR) | 0.49 | 1.07 |
| MACD | -0.05 | -0.38 |
| Stochastic Oscillator | 79.03 | 17.16 |
Price Performance
Historical ComparisonAbout MQ Marqeta Inc.
Headquartered in Oakland, California, and founded in 2010, Marqeta provides its clients with a card-issuing platform that offers the infrastructure and tools necessary to offer digital, physical, and tokenized payment options without the need for a traditional bank. The company's open APIs are designed to allow third parties like DoorDash, Klarna, and Block to rapidly develop and deploy innovative card-based products and payment services without the need to develop the underlying technology. The company generates revenue primarily through processing and ATM fees for cards issued on its platform.
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.